Sigrid

Sigrid is a consumer health company which specializes in metabolic diseases. From its funding announcement.

$5M UndisclosedRaised 9 months agoStockholm, SwedenHealthcare & MedtechSweden

In their own words

What Sigrid says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "consumer health company which specializes in metabolic diseases". Source

Market expansionResearch and development

Public signal Read from the company's own description of what the funding supports.

Why now

Where Sigrid is today

Sigrid announced a funding round of $5M on 7 January 2026.

Latest round
Undisclosed
Amount
$5M
Announced
7 January 2026
Headquarters
Stockholm, Sweden
Sector
Healthcare & Medtech
Growth stage
Growth
Investors
Not stated
Also participating
Not stated
Relevant leadership
CEO Sana Alajmovic

Momentum AfterRaise intelligence

AfterRaise Score

27
Established
0 funding signals in the last 90 days
Funding recency
9/40
announced within the last year
Round scale
8/25
round size relative to the market
Funding stage
10/20
Undisclosed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 7 January 2026
    $5M raised
    Investors not stated in the announcement.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • New market entry
  • First local hires in the new market
  • Local entity and legal setup
  • Research programme expansion

Opportunities this could create

  • Provider partnerships
  • Market-entry advisers
  • Local employment infrastructure
  • In-market partnerships
  • Scientific advisers

Based on the Healthcare & Medtech sector, a Growth round and the priorities the company itself set out. Not a statement of fact.

Early momentum3 connected signals
  • 7 January 2026$5M round announced
  • 7 January 2026Stated priority: market expansion
  • 7 January 2026Stated priority: research and development

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Sigrid is open to

Not yet specified

Sigrid has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Sigrid

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Sigrid?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: your website and the roles and projects you have open. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Healthcare & Medtech companies

See the sector